Setmelanotide Given FDA Priority Review for POMC and LEPR Deficiency

As an activator of the MC4R pathway, setmelanotide has the potential to lessen hyperphagia, or insatiable hunger, and help patients lose weight.

from Google Alert - How to lose weight https://ift.tt/2LuT38w